tallimustine has been researched along with Ovarian Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Incalci, M; Erba, E; Mascellani, E; Pifferi, A | 1 |
| D'Incalci, M; Filippini, C; Tagliabue, G; Ubezio, P | 1 |
2 other study(ies) available for tallimustine and Ovarian Neoplasms
| Article | Year |
|---|---|
Comparison of cell-cycle phase perturbations induced by the DNA-minor-groove alkylator tallimustine and by melphalan in the SW626 cell line.
Topics: Alkylating Agents; Bromodeoxyuridine; Cell Cycle; Distamycins; DNA; DNA, Neoplasm; Female; Flow Cytometry; Humans; In Vitro Techniques; Melphalan; Nitrogen Mustard Compounds; Nucleic Acid Conformation; Ovarian Neoplasms; Tumor Cells, Cultured | 1995 |
Combination of the new minor groove alkylator tallimustine and melphalan.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Distamycins; Female; Leukemia L1210; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neoplasm Transplantation; Nitrogen Mustard Compounds; Ovarian Neoplasms; Survival Rate | 1997 |